Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity

Antje Arnold, Ming Yuan, Antionette Price, Lauren Harris, Charles G. Eberhart, Eric H. Raabe

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity'. Together they form a unique fingerprint.

Medicine & Life Sciences